Autoantibodies to parathyroid hormone receptor

Area of Science:

• Nephrology
• Immunology
• Endocrinology

Background:

• Secondary hyperparathyroidism is common in uremia, characterized by elevated parathyroid hormone (PTH) levels.
• The exact mechanisms driving secondary hyperparathyroidism in uremia are not fully understood.

Purpose of the Study:

• To investigate the presence and role of autoantibodies targeting parathyroid hormone (PTH) receptors in uremic patients with secondary hyperparathyroidism.

Main Methods:

• Sera from 50 uremic patients with secondary hyperparathyroidism were analyzed for autoantibodies against PTH receptors.
• The functional impact of these antibodies on PTH-stimulated adenyl cyclase activity was assessed.

Main Results:

• Autoantibodies blocking PTH binding to its membrane receptors were detected in 49 out of 50 patients (IgG fraction).
• These species-specific antibodies were unaffected by dialysis and correlated with elevated C-regional PTH and uremia duration.
• The antibodies reduced cyclic adenosine monophosphate production in PTH-stimulated adenyl cyclase.

Conclusions:

• Secondary hyperparathyroidism in uremia represents a receptor-antibody disease.
• The autoantibodies likely interfere with PTH receptor function, either by altering receptor affinity or reducing receptor concentration.